Pathos
Chicago
About Pathos
Pathos is at the forefront of a novel approach to AI-driven drug development. This approach harnesses multimodal data, cutting-edge Artificial Intelligence, and profound clinical understanding to expedite the introduction of new therapies for patients. With an emphasis on Artificial Intelligence, clinical development, and implementation, Pathos is dedicated to enhancing patient outcomes by speeding up the transition from molecule to medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $447.0M
- Funding stage: Late Stage Venture
- Last round: Series D (May 2025)
- Website: pathos.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/pathos-21201 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.